• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,307 0.1%  Nikkei 19,107 -0.9%  EUR 1.0585 0.2% 
Nasdaq 5,845 0.2%  FTSE100 7,254 0.2%  Yen 112.2520 0.1%  Oil 56.5 0.7% 
S&P500 2,367 0.2%  DAX 11,808 0.0%  GBP 1.2414 -0.4%  Gold 1,256 -0.1% 

Gilead Sciences share [Symbol: GILD / ISIN: US3755581036]

Realtimequote Gilead Sciences Inc. in USD

Exchange Market
69.94
Last
0
Volume
Time 03:59 PM
02/24/2017 03:59:58 PM UTC-0500
activate push

Stock Price Gilead Sciences Inc. in USD

Activate push
69.94 USD 0.57 USD 0.82 %
Trade Time 8:10 PM Trade Date 2/24/2017
Daily High 0.00 Open 0.00
Daily Low 0.00 Prev. Close 69.94
52-week High 103.09 Volume (Qty.) 0
52-week Low 65.38 Market Cap (USD) 91.27 B
52-week Perf.
Exchange

Analyst Opinions for Gilead Sciences Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/11/13
Gilead Sciences boerse.de-Aktienbrief
01/10/13
Gilead Sciences Aktienservice Research
12/18/12
Gilead Sciences UBS AG
12/14/12
Gilead Sciences Goldman Sachs Group Inc.
11/15/12
Gilead Sciences RBC Capital Markets

Moody's Rating for Gilead Sciences Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A3
Rating Update AFF
Date of Rating 5/18/2016
Rating Office USA

Profile Gilead Sciences Inc.

Company Profile
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Its primary areas of focus include primary areas of focus include human immunodeficiency virus, liver diseases such as chronic hepatitis C virus infection and chronic hepatitis B virus infection, oncology and inflammation, and serious cardiovascular and respiratory conditions. Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
pagehit

Add or Edit Instrument

Gilead Sciences Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Gilead Sciences

2016 2017e 2018e
Dividend 1.84 2.15 2.30
Dividend Yield in % 2.55 3.17 3.39
P/E Ratio 6.23 7.87 8.71
EPS 11.57 8.63 7.79

Gilead Sciences Key Figures

Market Cap (USD) 91.27 B
Free Float in % 99.31
Number of Shares (Mio.) 1,310.00
Cash Flow per Share 11.82
Book Value per Share 14.67
60-Days Volatility 29.8
P/B Ratio 4.92

Base Data Gilead Sciences

Symbol GILD
ISIN US3755581036
Indices NASDAQ Comp., S&P 500, NASDAQ 100, BX Swiss - USA, S&P 400 MidCap, S&P 100

About the Company Gilead Sciences

Country USA

Gilead Sciences Historical Prices

02/23/2017
02/23/2017 06:00:00 PM UTC-0500
69.94 2,266,945
02/22/2017
02/22/2017 06:00:00 PM UTC-0500
69.37 2,070,711
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
68.83 3,187,825
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
69.29 2,653,092
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
69.85 3,378,865

Gilead Sciences Peer Group

Amgen 174.56
0.3%
AstraZeneca 46.20
0.1%
BB BIOTECH 57.30
1.1%
Biogen 285.13
0.1%
Biotest 18.53
-5.2%
Gilead Sciences 69.94
0.8%
GlaxoSmithKline 16.43
0.1%
Merck 66.16
0.5%
Merck 102.95
-0.2%
Novartis 77.70
0.3%
Pfizer 34.26
0.6%
Roche 243.60
0.5%
Roche 247.00
-0.4%
STADA Arzneimittel 57.50
0.1%

Similar shares with higher 1-year perf.